Search - tctmd.com

Displaying 161 - 180 of 318

Sort: Relevancy | Date

Presentation TCT 2014

Management of Arch Obstruction (Native and Recurrent) in Adults with Congenital Heart Disease

Presenter: Ziyad M. Hijazi, John F. Rhodes, Carlos Pedra, Matthew J. Gillespie

September 14, 2014

Presentation TCT 2014

Patent Ductus Arteriosus in the Adult: Assessment of Operability

Presenter: Ziyad M. Hijazi, John F. Rhodes, Carlos Pedra

September 14, 2014

Presentation TCT 2014

TCT 159: Patent Foramen Ovale Closure in Patients with Orthodeoxia-Platypnea Syndrome

Presenter: Stephen J.D. Brecker, Michael J. Mullen, Paul H. Kramer, Mohammad Mojadidi, MD

September 13, 2014

Presentation TCT 2014

TCT 158: Assessment of Sleep Apnea in Patients With and Without a Patent Foramen Ovale

Presenter: Stephen J.D. Brecker, Michael J. Mullen, Paul H. Kramer, Rubine Gevorgyan, MD

September 13, 2014

Presentation TCT 2014

PFO/ASD Closure with a New Bioreabsorbable Device: Important Advance?

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, Sameer Gafoor

September 13, 2014

Presentation TCT 2014

PFO and Sleep Apnea

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, Michael J. Mullen

September 13, 2014

Presentation TCT 2014

Orthodeoxia-Platypnea

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel, John C. Messenger

September 13, 2014

Presentation TCT 2014

Overview of PFO Closure for Migraines and Premium Trial Update

Presenter: Jonathan M. Tobis, Brian K. Whisenant, Carey D. Kimmelstiel

September 13, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, John D. Carroll

September 13, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation TCT 2014

Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Abel Romero-Corral

September 13, 2014

Presentation

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Presenter: S. Elmariah

August 20, 2014

News Daily News

Meta分析： PFO封堵相对于药物治疗的价值随器械而变

Caitlin E. Cox

August 20, 2014

News Daily News

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Caitlin E. Cox

August 20, 2014

News Daily News

Meta Análisis: El Valor del Cierre del FOP frente al Tratamiento Médico Depende del Dispositivo

Caitlin E. Cox

August 20, 2014

News Daily News

CLOSURE I Analysis Suggests Many Recurrent Strokes Are Unrelated to PFO

August 20, 2014

Presentation

Percutaneous Closure of Patent Foramen Ovale (PFO) in Patients with Cryptogenic Embolism

Presenter: S. Stortecky

August 14, 2014

Presentation Fellows 2014

PFO Closure: Indications and Technique

Presenter: Matthew Price

April 14, 2014

Presentation ECHO 2014

Imaging for Transcatheter Closure of ASD and VSD

Presenter: Robert J. Sommer

April 10, 2014

Advertisement

Management of Arch Obstruction (Native and Recurrent) in Adults with Congenital Heart Disease

Patent Ductus Arteriosus in the Adult: Assessment of Operability

TCT 159: Patent Foramen Ovale Closure in Patients with Orthodeoxia-Platypnea Syndrome

TCT 158: Assessment of Sleep Apnea in Patients With and Without a Patent Foramen Ovale

PFO/ASD Closure with a New Bioreabsorbable Device: Important Advance?

PFO and Sleep Apnea

Orthodeoxia-Platypnea

Overview of PFO Closure for Migraines and Premium Trial Update

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence?

Predictors of Recurrent Events in Patients with Cryptogenic Stroke and PFO in the CLOSURE I Trial

Meta分析： PFO封堵相对于药物治疗的价值随器械而变

Meta-analysis: Value of PFO Closure vs Medical Therapy Varies by Device

Meta Análisis: El Valor del Cierre del FOP frente al Tratamiento Médico Depende del Dispositivo

CLOSURE I Analysis Suggests Many Recurrent Strokes Are Unrelated to PFO

Percutaneous Closure of Patent Foramen Ovale (PFO) in Patients with Cryptogenic Embolism

PFO Closure: Indications and Technique

Imaging for Transcatheter Closure of ASD and VSD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content